We hear a lot about drug-resistant bacteria. The same thing can happen with viruses.
Academic rigor, journalistic flair
Articles on Direct-acting antivirals
Displaying all articles
Direct-acting antivirals can cure hepatitis C in eight to 12 weeks. But while the rate of uptake in Australia has slowed, a greater proportion of those undertaking treatment are in prison.
It seems as though every other day we’re told a cure has been found for coronavirus. This is not strictly true – but there are some therapeutic options showing promise.
If England eliminates hepatitis C, it will be the first country to do so. But how feasible is it?
Top contributors
-
Professor of Cancer Virology, University of Leeds
-
Chair Professor, University of Manchester
-
Chair in Graduate Education, University of Manchester
-
Senior Lecturer, Head of the Viruses and Cytokine Biology group in the School of Life Science, University of Technology Sydney
-
Director, Gastroenterology Department, St Vincent's Hospital, The University of Melbourne
-
Lead Policy Officer, Burnet Institute
-
Deputy Head, Justice Health Research Group, Burnet Institute
-
Clinical Associate Professor, The University of Melbourne
-
Assistant researcher, The University of Melbourne
